EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A nomogram based on baseline predictors for Graves’ disease relapse after antithyroid drug withdrawal: a retrospective study

Ruohan Dai, Mingrui Li, Yaohua Chen, Jiasi Wang, Hongquan Xiong

Frontiers in Endocrinology · 2026

DOI: 10.3389/fendo.2026.1968560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2026. Verfasst von Ruohan Dai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Dazhou Central Hospital, Dazhou, China. Hauptthemen laut MEDLINE: Graves Disease, Nomograms, Antithyroid Agents, Withholding Treatment. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop and validate a practical prediction model for relapse of Graves’ disease within one year after discontinuation of antithyroid drugs, using routinely available baseline characteristics, and to compare its performance with an existing score.

Methods

This single-center retrospective cohort study enrolled 654 adults with Graves’ disease who achieved remission after at least 12 months of antithyroid drug therapy and subsequently discontinued treatment. The cohort was randomly split into training (70%) and testing (30%) sets. Predictors were selected by least absolute shrinkage and selection operator (LASSO) regression, and a multivariable logistic regression model was built on multiply imputed data. Model performance was assessed by discrimination, calibration, and decision curve analysis and was benchmarked against the Graves Recurrent Events After Therapy (GREAT) score. A nomogram was constructed to visualize individualized risk.

Results

Five independent baseline predictors emerged: younger age, male sex, goiter grade 2–3, higher free thyroxine, and higher thyrotropin receptor antibody. The model demonstrated good discrimination, with an area under the receiver operating characteristic curve of 0.84 in the testing set, which showed discrimination comparable to that of the GREAT score (0.82; DeLong P = 0.31). Across quartiles of predicted probability, the observed relapse rate increased from 23.4% to 97.9% (test for trend p < 0.001). Calibration was satisfactory, and decision curve analysis indicated net clinical benefit across relevant threshold probabilities. The nomogram translates these five variables into a single probability of relapse. An interactive online calculator was concurrently developed to facilitate clinical use.

Conclusions

Readily accessible clinical and laboratory parameters can identify patients at elevated risk of early relapse after antithyroid drug withdrawal for Graves’ disease. The proposed nomogram offers a simple, quantitative tool to support personalized treatment discussions and shared decision-making, although external validation in diverse populations is necessary before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseNomogramsAntithyroid AgentsWithholding TreatmentHumansRetrospective StudiesRecurrenceFemaleMaleAdultMiddle AgedPrognosis

Stichwörter der Autor:innen

GREAT scoreGraves’ diseaseantithyroid drugsnomogramrelapserisk prediction

Substanzen

Antithyroid Agents

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Dazhou Central Hospital, Dazhou, China.
  • Department of Pulmonary and Critical Care Medicine, Dazhou Central Hospital, Dazhou, China.
  • Clinical Medicine Research Center, Dazhou Central Hospital, Dazhou, China.
  • Department of Otolaryngology-Head and Neck Surgery, Dazhou Central Hospital, Dazhou, China.

Zitieren

APA

Dai, R., Li, M., Chen, Y., Wang, J., & Xiong, H. (2026). A nomogram based on baseline predictors for Graves’ disease relapse after antithyroid drug withdrawal: a retrospective study. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1968560

Vancouver

Dai R, Li M, Chen Y, Wang J, Xiong H. A nomogram based on baseline predictors for Graves’ disease relapse after antithyroid drug withdrawal: a retrospective study. Frontiers in Endocrinology. 2026. doi:10.3389/fendo.2026.1968560

BibTeX
@article{Dai2026,
  author = {Dai, Ruohan and Li, Mingrui and Chen, Yaohua and Wang, Jiasi and Xiong, Hongquan},
  title = {A nomogram based on baseline predictors for Graves’ disease relapse after antithyroid drug withdrawal: a retrospective study},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  doi = {10.3389/fendo.2026.1968560}
}
Kostenlos starten →